Berner K, Hernes E, Kvassheim M, Revheim ME, Bastiansen J, Selboe S, Bakken CL, Grønningsæter SR, Bruland ØS, Larsen RH, Bouzelmat L, Jardine VL, Stokke C(2025) First-in-Human Phase 0 Study of AB001, a Prostate-Specific Membrane Antigen-Targeted 212Pb Radioligand, in Patients with Metastatic Castration-Resistant Prostate Cancer J Nucl Med, 66(5), 732-738 DOI 10.2967/jnumed.124.269299, PubMed 40081958
Høyvik AJK, Kvassheim M, Ma LW, Wiig E, Hillestad T, Revheim ME, Liukaityte R, Bruland Ø, Juzeniene A(2025) Therapeutic evaluation of [212Pb]Pb-AB001 and [177Lu]Lu-PSMA-617 in a mouse model of disseminated prostate cancer Eur J Nucl Med Mol Imaging(in press) DOI 10.1007/s00259-025-07330-y, PubMed 40397137
Koffi E, Padilla CS, Drabbe C, Schreuder WH, Zemouri C, den Hollander D, Grünhagen DJ, Sodergren S, Singer S, Jones RL, Desar IME, Fauske L, Pinto M, Nixon I, Salah S, Bruland ØS, Soomers VLMN, van de Sande MAJ, de Haan JJ, Verhoef C, Steggink LC, van Houdt WJ, Bootsma TI, Tesselaar MT, van der Graaf WTAet al.(2025) Health-Related Quality of Life in Patients With a Head and Neck Sarcoma: A Mixed-Methods Study Head Neck(in press) DOI 10.1002/hed.28226, PubMed 40583369
